Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
|
tacrine
|
acetylcholinesterase inhibitor
|
|
|
donepezil
|
acetylcholinesterase inhibitor
|
|
|
rivastigmine
|
acetylcholinesterase inhibitor
|
|
|
galantamine
|
acetylcholinesterase inhibitor
|
|
|
memantine
|
NMDA recptor antagonist
treats: moderate to severe alzheimers side effects: mild headache and dizziness |
|
|
Risperidone
|
mechanism: DA2 and 5-HT2A receptor blocker
uses: antipsychotic, Schizophrenia, bipolar, symptoms of AD AE: orthostatic hypotension, hyperprolactemia, somnolence |
|
|
olanzapine
|
mechanism: DA2 and 5-HT2A receptor blocker
uses: antipsychotic, Schizophrenia, bipolar, symptoms of AD AE: orthostatic hypotension, |
|
|
quetiapine
|
mechanism: DA2 and 5-HT2A receptor blocker
uses: antipsychotic, Schizophrenia, bipolar, symptoms of AD AE: orthostatic hypotension, |
|
|
sertraline
|
mechanism: SSRI
uses: antidepressant AE: nausea, vomiting, agitation, akathisia, sexual dysfunction, appetite change |
|
|
paroxetine
|
mechanism: SSRI
uses: antidepressant AE: nausea, vomiting, agitation, akathisia, sexual dysfunction, appetite change |
|
|
citalopram
|
mechanism: SSRI
uses: antidepressant AE: nausea, vomiting, agitation, akathisia, sexual dysfunction, appetite change |
|
|
riluzole
|
mechanism: potassium channel activator, decreases glutamate release, decreases excitotoxicity
uses: ALS |
|
|
baclofen
|
mechanism: GABA B agonist
uses: reduces spasticity in ALS |
|
|
tizanidine
|
mechanism: CNS alpha 2 agonist
uses: reduces spasticity in ALS |
|
|
benzodiazepines
|
mechanism: potentiates GABA A
uses: decreases spasticity in moderate ALS, not for advanced ALS |
|
|
fluoxetine
|
mechanism: SSRI
|
|
|
carbamazepine
|
mechanism: blocks sodium channel
use: antidepressant, antipsychotic |
|
|
clozapine
|
mechanism: blocks D1, D4
use: antipsychotic |
|
|
reserpine
|
mechanism: Reserpine acts by blocking the vesicular monoamine transporter VMAT, which normally transports free norepinephrine, serotonin, and dopamine from the cytoplasm of the presynaptic nerve into vesicles for subsequent release into the synaptic cleft. The unprotected neurotransmitters are then metabolized by MAO and therefore never reach the synapse
uses: HTN, large chores AE: hypotension, depression, PD symptoms |
|
|
tetrabenazine
|
mechanism: depletes dopamine
use: for large chorea AE: hypotension, depression, PD symptoms |
|
|
haloperidol
|
mechanism: dopamine receptor blocker
use: for large chorea |
